New head appointed at Novozymes OneHealth North America
Guillermo (Willy) Pardiñas now serves as head of Novozymes OneHealth North America, a company specializing in ingredients such as probiotics, enzymes, and other bioactives.
Pictured: Guillermo (Willy) Pardiñas. Photo from Novozymes OneHealth.
Novozymes OneHealth, a B2B supplier specializing in ingredients such as probiotics, enzymes, and other bioactives, has appointed a new head at its Novozymes OneHealth North America division. Guillermo (Willy) Pardiñas now serves as head of Novozymes OneHealth North America.
Pardiñas’s experience in the nutraceuticals industry includes working for more than a decade at Abbott Labs in the U.S., Thailand, and Mexico, as well as serving as senior vice president, general manager–Americas, at Metagenics.
“With a unique vantage point and prior industry experience that spans multiple departments, functions, and geographies, Willy has demonstrated an exceptional ability to analyze business challenges from a strategic, high-level perspective while never losing sight of the human elements at the core of our work,” stated Ulrich Irgens, general manager (VP) of Novozymes OneHealth, in a press release.
HHS announces restructuring plans to consolidate divisions and downsize workforce
Published: March 27th 2025 | Updated: March 27th 2025According to the announcement, the restructuring will save taxpayers $1.8 billion per year by reducing the workforce by 10,000 full-time employees and consolidating the department’s 28 divisions into 15 new divisions.
